15d-PGJ 2 -loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice

• Published in: Scientific reports 2018-09, Vol.8 (1), p.13979
• Main Authors: Ruiz-Miyazawa, Kenji W, Staurengo-Ferrari, Larissa, Pinho-Ribeiro, Felipe A, Fattori, Victor, Zaninelli, Tiago H, Badaro-Garcia, Stephanie, Borghi, Sergio M, Andrade, Ketlem C, Clemente-Napimoga, Juliana T, Alves-Filho, Jose C, Cunha, Thiago M, Fraceto, Leonardo F, Cunha, Fernando Q, Napimoga, Marcelo H, Casagrande, Rubia, Verri, Jr, Waldiceu A
• Format: Article
• Language: English
• ISSN: 2045-2322

Gout arthritis (GA) is a painful inflammatory disease in response to monosodium urate (MSU) crystals in the joints. 15deoxy-Δ -prostaglandin J (15d-PGJ ) is a natural activator of PPAR-γ with analgesic, anti-inflammatory, and pro-resolution properties. Thus, we aimed to evaluate the effect and mechanisms of action of 15d-PGJ nanocapsules (NC) in the model of GA in mice, since a reduction of 33-fold in the dose of 15d-PGJ has been reported. Mice were treated with 15d-PGJ -loaded NC, inert NC, free 15d-PGJ (without NC), or 15d-PGJ -loaded NC+ GW9662, a PPAR-γ inhibitor. We show that 15d-PGJ -loaded NC provided analgesic effect in a dose that the free 15d-PGJ failed to inhibiting pain and inflammation. Hence, 15d-PGJ -loaded NC reduced MSU-induced IL-1β, TNF-α, IL-6, IL-17, and IL-33 release and oxidative stress. Also, 15d-PGJ -loaded NC decreased the maturation of IL-1β in LPS-primed BMDM triggered by MSU. Further, 15d-PGJ -loaded NC decreased the expression of the components of the inflammasome Nlrp3, Asc, and Pro-caspase-1, as consequence of inhibiting NF-κB activation. All effects were PPAR-γ-sensitive. Therefore, we demonstrated that 15d-PGJ -loaded NC present analgesic and anti-inflammatory properties in a PPAR-γ-dependent manner inhibiting IL-1β release and NF-κB activation in GA. Concluding, 15d-PGJ -loaded NC ameliorates MSU-induced GA in a PPAR-γ-sensitive manner.